bf/NASDAQ:AMGN_icon.jpeg

NASDAQ:AMGN

Amgen Inc.

  • Stock

USD

Last Close

315.59

06/11 21:54

Market Cap

172.56B

Beta: 0.64

Volume Today

2.90M

Avg: 2.46M

PE Ratio

22.81

PFCF: 17.94

Dividend Yield

2.64%

Payout:58.90%

    Description

    Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low w...Show More

    Earnings

    Earnings per Share (Estimate*)

    123452017-04-262019-04-302021-04-272023-04-272024-10-30

    Revenue (Estimate*)

    2B4B6B8B2017-04-262019-04-302021-04-272023-04-272024-10-30

    *Estimate based on analyst consensus